HDAC3 and Its Role in Inflammation
Author Information
Author(s): Ruyuan He, Zhuokun He, Tianyu Zhang, Bohao Liu, Minglang Gao, Ning Li, Qing Geng
Primary Institution: Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China
Hypothesis
This review examines the involvement of HDAC3 in inflammatory responses while exploring its therapeutic potential as a target for treating inflammatory diseases.
Conclusion
HDAC3 plays a crucial role in regulating inflammation and has potential as a therapeutic target for inflammatory diseases.
Supporting Evidence
- HDAC3 regulates various inflammatory mediators and enzymes, affecting downstream gene expression.
- HDAC3 inhibitors have shown promise in reducing inflammation in various disease models.
- Targeting HDAC3 may provide therapeutic benefits in diseases like cardiovascular and neurodegenerative disorders.
Takeaway
HDAC3 is a protein that helps control inflammation in the body, and scientists think it could be a good target for new medicines to treat diseases caused by inflammation.
Methodology
This is a review article summarizing existing research on HDAC3's role in inflammation.
Limitations
The review highlights the complexity of HDAC3's functions and the need for further research to fully understand its non-enzymatic roles.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website